|Source||Humanized (from mouse)|
|14px (what is this?)|
Labetuzumab (marketed under the trade name CEA-CIDE) is a humanized IgG1 monoclonal antibody for the treatment of colorectal cancer. It selectively binds to carcinoembryonic cell adhesion molecule 5. 
This drug was developed by Immunomedics, Inc.
- Statement On A Nonproprietary Name Adopted By The Usan Council - Labetuzumab, American Medical Association.
Lua error in package.lua at line 80: module 'Module:Buffer' not found. Lua error in package.lua at line 80: module 'Module:Buffer' not found.